Lansdowne, PA, United States of America

Ruth F Pereira

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Thomas Jefferson University. Active years: 1998-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth F Pereira. Retrieved from https://idiyas.com/inventor/ruth-f-pereira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 257(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1998)
  • Lansdowne, PA (US) (1998 - 2005)

Company Filing History:


Years Active: 1998-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ruth F Pereira: Innovator in Stem Cell Therapy

Introduction

Ruth F Pereira is an accomplished inventor based in Lansdowne, PA, recognized for her significant contributions to the field of stem cell therapy. With three patents to her name, she focuses on innovative methods for treating various diseases, particularly those involving bone, cartilage, and lung defects.

Latest Patents

Her latest patents include groundbreaking methods for isolating stromal cells and their applications in therapeutic treatments. One notable patent describes methods for treating patients suffering from diseases characterized by bone cartilage or lung defects. This method involves the intravenous administration of stromal cells isolated from either syngeneic individuals or from the patients themselves after correcting the genetic defect in these isolated cells.

Another significant patent involves implant devices that contain stromal cells isolated from bone marrow, which are engineered with a gene construct. This construct is designed to encode a beneficial protein, paired with regulatory elements that function effectively within stromal cells. Furthermore, she has developed methods to treat individuals with conditions characterized by gene defects by introducing stromal cells that are physically isolated from the recipient's immune system, ensuring effective treatment.

Additionally, Pereira's research includes the use of a COL1A1 mini-gene construct to inhibit collagen synthesis, providing innovative methods for controlling the production of type I procollagen in cells, thereby influencing collagen deposition in tissues.

Career Highlights

Ruth F Pereira is affiliated with Thomas Jefferson University, where she has made significant strides in stem cell research and treatment methodologies. Her work has garnered attention for its potential to revolutionize how diseases related to defective genes are approached and treated, greatly benefiting individuals who suffer from such conditions.

Collaborations

Throughout her career, Pereira has collaborated with noted experts in her field, including Darwin J Prockop and Dennis B Leeper. These partnerships highlight her commitment to advancing research in stem cell therapy and her ability to work effectively within multidisciplinary teams.

Conclusion

Ruth F Pereira's innovative contributions to the fields of stem cell therapy and gene therapy are helping to drive advancements in medical treatment for various disorders. Her patents not only reflect her creativity and expertise but also provide hope for patients with conditions previously deemed challenging to treat. As research continues to evolve, Pereira's work will undoubtedly pave the way for new therapeutic techniques and products in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…